Junru Chen

No.1, Donggang West Road
Lanzhou, 730000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Pan-cancer investigation regarding the prognostic predictive and immunological regulation functions of PGK1 and experimental validation in esophageal squamous cell carcinoma.

Pan-cancer investigation regarding the prognostic predictive and immunological regulation functions of PGK1 and experimental validation in esophageal squamous cell carcinoma.

Journal: Functional & integrative genomics

Published: December 25, 2024

Inhibition of Phosphoglycerate Kinase 1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma to X-rays and Carbon Ion Irradiation.

Inhibition of Phosphoglycerate Kinase 1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma to X-rays and Carbon Ion Irradiation.

Journal: Frontiers in bioscience (Landmark edition)

Published: December 18, 2024

Reply to Comment on Ou Y, et al. "UBA2 as a Prognostic Biomarker and Potential Therapeutic Target in Glioma". Frontiers in Bioscience-Landmark. 2024; 29: 144.

Reply to Comment on Ou Y, et al. "UBA2 as a Prognostic Biomarker and Potential Therapeutic Target in Glioma". Frontiers in Bioscience-Landmark. 2024; 29: 144.

Journal: Frontiers in bioscience (Landmark edition)

Published: September 20, 2024

14-3-3σ downregulation sensitizes pancreatic cancer to carbon ions by suppressing the homologous recombination repair pathway.

14-3-3σ downregulation sensitizes pancreatic cancer to carbon ions by suppressing the homologous recombination repair pathway.

Journal: Aging

Published: November 20, 2023

UBA2 as a Prognostic Biomarker and Potential Therapeutic Target in Glioma.

UBA2 as a Prognostic Biomarker and Potential Therapeutic Target in Glioma.

Journal: Frontiers in bioscience (Landmark edition)

Published: November 06, 2023

Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions.

Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions.

Journal: Journal of Cancer

Published: September 21, 2023

Efficacy and safety of carbon ion radiotherapy for chordomas: a systematic review and meta-analysis.

Efficacy and safety of carbon ion radiotherapy for chordomas: a systematic review and meta-analysis.

Journal: Radiation oncology (London, England)

Published: June 26, 2023

LIF Inhibits Proliferation of Esophageal Squamous Carcinoma Cells by Radiation Mediated Through JAK-STAT Signaling Pathway.

LIF Inhibits Proliferation of Esophageal Squamous Carcinoma Cells by Radiation Mediated Through JAK-STAT Signaling Pathway.

Journal: Journal of Cancer

Published: November 25, 2022

Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis.

Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis.

Journal: Radiation oncology (London, England)

Published: October 15, 2022

Charged particle therapy for high-grade gliomas in adults: a systematic review.

Charged particle therapy for high-grade gliomas in adults: a systematic review.

Journal: Radiation oncology (London, England)

Published: October 14, 2022

Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis.

Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis.

Journal: Radiation oncology (London, England)

Published: April 21, 2022

Charged Particle Irradiation for Pancreatic Cancer: A Systematic Review of In Vitro Studies.

Charged Particle Irradiation for Pancreatic Cancer: A Systematic Review of In Vitro Studies.

Journal: Frontiers in oncology

Published: September 14, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026